Prof. Dr. med. Thomas Valerius 

Facts

Phone: +49-431-500-22701
Affiliations: Division of Stem Cell Transplantation and Immunotherapy / University Medical Center Schleswig-Holstein, Campus Kiel, Clinic for Internal Medicine II, Hematology and Oncology / University Medical Center Schleswig-Holstein, Campus Kiel
Address: Rosalind-Franklin-Str. 12, 24105 Kiel

Curriculum vitae

Education/Training

Since 05/2019Deputy Clinical Director of the Section for Stem Cell Transplantation and Immunotherapy, UKSH Kiel
2008-2019 Senior Attending Physician at the Section for Stem Cell Transplantation and Immunotherapy, UKSH Kiel 
2003-2008 Attending Physician at the Department of Nephrology, UKSH Kiel 
2003 Board Certification “Rheumatology” and “Hematology and Oncology” 
1990-1996 Training in Internal Medicine; Board Certification 1996 
1982-1989 Medical Studies at the University of Erlangen 

Research Experience/Academic Appointments

2006 Appointment as Associate Professor 
1998 Habilitation 
1994 Medical Thesis (summa cum laude) 

Project-related publications

P1, P3, P4, P6, P7, P8, INF

Myeloid cell–mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference

Lustig M, Kowol M, Hartmann AM, van der Peet IC, Jansen MJH, Iben K, Winterberg D, Krohn S, Baumann N, Rösner T, Bendig S, Hahn C, Wurm AA, Gehlert CL, Denker M, Suwanchaikasem P, Macarrón Palacios A, Schwartz S, Brüggemann M, Burger R, Schmitt K, Klausz K, Valerius O, Stölzel F, Bastian L, Baldus CD, Peipp M, Leusen JHW, Schewe DM, Valerius T.

Blood Neoplasia
2026

Participating Institutes